HSC activation results in redistribution of LDs and is accompanied by a decrease in size. by Nicole Testerink (169448)

Neudesin: a neuropeptide hormone decreased in subjects with polycystic ovary syndrome by Giray Bozkaya (8739405)

PB2 variants D605A and V606A do not affect the secondary structures of the PB2 ‘627’ domain. by Ho-Pan Hsia (4768638)

The activity of platelet P2Y1, but not of P2X1 or P2Y12 receptor, continually decreases in citrated WB. by Juergen Koessler (847843)

TGF-β1 had little effect on MMP-2, MMP-3 and MMP-14 expression, but decreased expression of MMP-16. by Youssef M. Farhat (295089)

HIF-1α knockdown and TGF-β blockade decreases VEGF and CXCR4 mRNA expression <i>in vitro</i>. by Lauren K. Dunn (260121)

Comparison of human measures of motor learning across the Start phase (5 first games) and the Middle phase (5 middle games) of <i>Auto Orbit</i>. by Pierre Giovanni Gianferrara (11553077)

Downhill Running-Based Overtraining Protocol Improves Hepatic Insulin Signaling Pathway without Concomitant Decrease of Inflammatory Proteins - Fig 2 by Alisson L. da Rocha (804331)

LAP whole blood displays Increased capacity for 5-HETE and LTB₄ levels, and decreased for 12-HETE, 14-HDHA, 15-HETE and LXA₄. by Gabrielle Fredman (272178)

Transgenic <i>Eμ-V_H-OBF1</i> mice are immunodeficient due to decreased numbers of follicular B cells. by Alain Bordon (57422)

C/EBPα binds five sites within the <i>Cebpa</i> +8 kb enhancer. by Lei Peng (260321)

Subjects:

Blocking CD4, integrins, and lectins simultaneously significantly decreased DC binding and uptake of both free and complement opsonized HIV-1. by Veronica Tjomsland (210021)

mGluR5 binding potential (BP_ND) decreased in epilepsy models according to time periods after status epilepticus. by Hongyoon Choi (541919)

“…<p>(A–C) BP_ND decreased globally in acute period after status epilepticus. …”

Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis by Eric N. Ouattara (6890174)

“…Outcomes from the model included life expectancy, 10-year medical resource use, incremental cost-effectiveness ratios (ICERs) in $/year of life saved (YLS), and 5-year budget impact. We simulated people with HIV (PWH) in care (mean CD4: 259/<i>μ</i>L, SD 198/<i>μ</i>L) and transmitted cases. …”

Vasodilator effect of BPP-BrachyNH₂ and captopril (10⁻⁹–3 × 10⁻⁵ M) on rat thoracic aorta. by Daniel Dias Rufino Arcanjo (536744)

CDK5 knockdown increases TP53 and p27^Kip1 protein half-lives, increases nuclear localization of the two proteins, decreases p27^Kip1 p-T187 phosphorylation and induces p21^Cip1 in a TP53-dependent manner. by Shu Zhang (22238)

“…<p>(<b>A</b>) Transfection with CDK5 siRNA increased the half-life of p53 and p27^Kip1 protein. …”

DCB-3503 did not decrease mRNA levels of cyclin D1, survivin, β-catenin, p53, and p21. by Ying Wang (11406)

S1 Data - by Marc S. Penn (16624541)

Subjects:

Activation of vMC-dDG pathway decreases the competitive advantage of fear engram cells in the dDG neuronal network and attenuates fear generalization. by Kun Cui (2070772)

Measurement of mitochondrial superoxide anion production in HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG. by Patrick Mordel (17020879)